OraSure Technologies Other Operating Income or Expenses 2010-2024 | OSUR
OraSure Technologies Annual Other Operating Income or Expenses (Millions of US $) |
|
---|---|
2024 | $-4 |
2023 | $-11 |
2022 | $-17 |
2021 | $1 |
2020 | $1 |
2019 | $11 |
2018 | $0 |
2017 | $13 |
2016 | $0 |
2015 | $0 |
2014 | $6 |
2013 | $8 |
2012 | $0 |
2011 | $0 |
2010 | $0 |
2009 | $-4 |
OraSure Technologies Quarterly Other Operating Income or Expenses (Millions of US $) |
|
---|---|
2024-12-31 | $0 |
2024-09-30 | $0 |
2024-06-30 | $-1 |
2024-03-31 | $-3 |
2023-12-31 | $-3 |
2023-09-30 | $-6 |
2023-06-30 | $0 |
2023-03-31 | $-1 |
2022-12-31 | $0 |
2022-09-30 | $-7 |
2022-06-30 | $-11 |
2022-03-31 | $0 |
2021-12-31 | $0 |
2021-09-30 | $1 |
2021-06-30 | $0 |
2021-03-31 | $1 |
2020-12-31 | $1 |
2020-09-30 | $0 |
2020-06-30 | $1 |
2020-03-31 | $-1 |
2019-12-31 | $0 |
2019-09-30 | $13 |
2019-06-30 | $0 |
2019-03-31 | $-1 |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | $13 |
2016-12-31 | |
2016-09-30 | |
2016-06-30 | |
2016-03-31 | |
2015-12-31 | |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | $6 |
2014-03-31 | |
2013-12-31 | |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | |
2011-12-31 | |
2011-09-30 | |
2011-06-30 | |
2011-03-31 | |
2010-12-31 | |
2010-09-30 | |
2010-06-30 | |
2010-03-31 | |
2009-12-31 | $-1 |
2009-09-30 | |
2009-06-30 | $-3 |
2009-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.232B | $0.186B |
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
Boston Scientific (BSX) | United States | $152.152B | 38.10 |
Stryker (SYK) | United States | $142.721B | 30.67 |
EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
Medtronic (MDT) | Ireland | $108.708B | 15.87 |
Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
ResMed (RMD) | United States | $34.691B | 26.06 |
GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
Agilent Technologies (A) | United States | $30.677B | 20.26 |
Terumo (TRUMY) | Japan | $28.397B | 0.00 |
Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
Insulet (PODD) | United States | $17.717B | 75.76 |
Baxter (BAX) | United States | $15.988B | 11.50 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
Demant (WILYY) | Denmark | $7.600B | 0.00 |
Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.362B | 28.64 |
Haemonetics (HAE) | United States | $3.166B | 14.90 |
Envista Holdings (NVST) | United States | $2.725B | 22.03 |
GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
AtriCure (ATRC) | United States | $1.480B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
Neogen (NEOG) | United States | $1.096B | 14.03 |
InMode (INMD) | Israel | $0.981B | 8.98 |
Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
Evolus (EOLS) | United States | $0.735B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
CeriBell (CBLL) | United States | $0.577B | 0.00 |
Owens & Minor (OMI) | United States | $0.545B | 4.64 |
Valneva SE (VALN) | France | $0.531B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
Omeros (OMER) | United States | $0.427B | 0.00 |
Surmodics (SRDX) | United States | $0.400B | 0.00 |
SNDL (SNDL) | Canada | $0.392B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
Cerus (CERS) | United States | $0.252B | 0.00 |
ZimVie (ZIMV) | United States | $0.252B | 15.10 |
Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
Quanterix (QTRX) | United States | $0.223B | 0.00 |
High Tide (HITI) | Canada | $0.195B | 0.00 |
Biote (BTMD) | United States | $0.182B | 4.16 |
Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
Brainsway (BWAY) | Israel | $0.164B | 51.00 |
Organigram Global (OGI) | Canada | $0.146B | 0.00 |
Jin Medical (ZJYL) | China | $0.142B | 0.00 |
FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
Agape ATP (ATPC) | $0.115B | 0.00 | |
Exagen (XGN) | United States | $0.112B | 0.00 |
MacroGenics (MGNX) | United States | $0.109B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
Veru (VERU) | United States | $0.079B | 0.00 |
Fonar (FONR) | United States | $0.078B | 10.91 |
InterCure (INCR) | Israel | $0.072B | 0.00 |
United Health Products (UEEC) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
Zynex (ZYXI) | United States | $0.050B | 0.00 |
ImmuCell (ICCC) | United States | $0.049B | 0.00 |
Modular Medical (MODD) | United States | $0.044B | 0.00 |
Apyx Medical (APYX) | United States | $0.039B | 0.00 |
Safety Shot (SHOT) | United States | $0.039B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
United-Guardian (UG) | United States | $0.036B | 11.14 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
INLIF (INLF) | $0.018B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
Flora Growth (FLGC) | United States | $0.011B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |